Brief: Oncternal Therapeutics And Celularity Enter Into Research Collaboration To Evaluate Targeted Placental-Derived Cellular Therapies
20/09/2021 13:18
Sept 20 (Reuters) - Celularity Inc CELU.O :
* ONCTERNAL THERAPEUTICS AND CELULARITY ENTER INTO RESEARCH
COLLABORATION TO EVALUATE TARGETED PLACENTAL-DERIVED CELLULAR
THERAPIES
Source text for Eikon: ID:nGNX7t0LGt
Further company coverage: CELU.O
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform